Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

889

Participants

Timeline

Start Date

June 2, 2009

Primary Completion Date

February 7, 2025

Study Completion Date

December 15, 2030

Conditions
Anxiety DisorderCognitive/Functional EffectsColorectal CancerDepressionFatiguePsychosocial Effects of Cancer and Its TreatmentSleep DisordersExcercise
Interventions
BEHAVIORAL

exercise intervention

3 phases Phase 1: Intensive intervention for 6 months Phase 2: Reduced intervention for months 6-12 Phase 3: Minimal intervention for months 12-36

OTHER

counseling intervention

Achieving an increase in PA from baseline of ≥ 10 MET hours/week will require a significant amount of behavioural support. The intervention will comprise a 36-month individualized PA and behavioural support program with a PAC. This will include a personalized PA prescription which takes into account the baseline fitness test results, PA history, performance status and patient's personal PA preferences and any barriers to activity. Most patients are likely to choose a walking program however any PA of at least moderate intensity level is acceptable.

OTHER

educational intervention

Once at the beginning of the program

OTHER

laboratory biomarker analysis

Every 12 months

OTHER

questionnaire administration

Every 6 months

OTHER

study of socioeconomic and demographic variables

Every 6 months

PROCEDURE

fatigue assessment and management

Every 6 months

PROCEDURE

quality-of-life assessment

Every 6 months

OTHER

Educational Intervention

For Arm 2 just once at beginning of program.

OTHER

Fitness testing

Objective fitness testing for both arms

Trial Locations (47)

2050

Royal Prince Alfred Hospital, Camperdown

2065

Royal North Shore Hospital, St Leonards

2076

Sydney Adventist Hospital, Wahroonga

2139

Concord Repatriation General Hospital, Concord

2170

Liverpool Hospital, Liverpool

2200

Bankstown-Lidcombe Hospital, Bankstown

2305

Newcastle Private Hospital, Newcastle

2340

Tamworth Hospital, Tamworth

2350

Armidale Hospital, Armidale

2444

North Coast Cancer Institute - Port Macquarie, Port Macquarie

2450

North Coast Cancer Institute Coffs Harbour, Coffs Harbour

2560

Macarthur Cancer Therapy Centre - Campbelltown Hospital, Campbelltown

2650

Riverina Cancer Care Centre, Wagga Wagga

3065

St Vincent's Hospital Melbourne, Fitzroy

4029

Royal Brisbane and Women's Hospital, Herston

4102

Princess Alexandra, Woolloongabba

5000

Royal Adelaide Hospital, Adelaide

5011

The Queen Elizabeth Hospital, Woodville

5042

Flinders Medical Centre, Bedford Park

6000

Royal Perth Hospital, Perth

48202

Henry Ford Hospital, Detroit

03756

Dartmouth-Hitchcock, Lebanon

27599-1651

University of North Carolina at Chapel Hill, Chapel Hill

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

R3E 0V9

CancerCare Manitoba, Winnipeg

E3B 5N5

Horizon Health Network, Fredericton

E1C 6Z8

The Moncton Hospital, Moncton

E2L 4L2

Regional Health Authority B, Zone 2, Saint John

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 2V7

Kingston Health Sciences Centre, Kingston

N2G 1G3

Grand River Regional Cancer Centre, Kitchener

N6A 5W9

London Regional Cancer Program, London

L5M 2N1

Trillium Health Partners - Credit Valley Hospital, Mississauga

L3Y 2P9

Stronach Regional Health Centre at Southlake, Newmarket

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

L2S 0A9

Niagara Health System, St. Catharines

M4G 1R7

Toronto Rehab, Toronto

M4N 3M5

Odette Cancer Centre, Toronto

M5G 1X5

Sinai Health System, Toronto

G6V 3Z1

Lévis

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon

CEDEX 5

Montpellier

Unknown

Exercise Medicine Center for Diabetes and Cancer, Seoul

BT9 7AB

Belfast City Hospital, Belfast

All Listed Sponsors
collaborator

Survivorship Research Group

UNKNOWN

collaborator

Queen's University, Belfast

OTHER

lead

Canadian Cancer Trials Group

NETWORK